Table 1.
Patients’ characteristics
| Characteristics | N(%) |
|---|---|
| Sex | |
| Male | 24 (85.7) |
| Female | 4 (14.3) |
| Age | |
| Median | 63 |
| Range | 42–77 |
| Smoking index | |
| 0 | 7 (25.0) |
| 1–400 | 1 (3.6) |
| ≥ 400 | 20 (71.4) |
| KPS status | |
| 70 | 2 (7.1) |
| 80 | 16 (57.1) |
| 90 | 9 (32.1) |
| 100 | 1 (3.6) |
| Weight loss within 6 months before the treatment | |
| 0 | 19 (67.9) |
| <5% | 4 (14.3) |
| ≥ 5% | 5 (17.9) |
| T stage | |
| T1 | 1 (3.6) |
| T2 | 10 (35.7) |
| T3 | 9 (32.1) |
| T4 | 8 (28.6) |
| N stage | |
| N1 | 3 (10.7) |
| N2 | 9 (32.1) |
| N3 | 16 (57.1) |
| Clinical stage | |
| IIIA | 7 (25.0) |
| IIIB | 21 (75.0) |
| Histological type | |
| • Squamous cell carcinoma | 15 (53.6) |
| Adenocarcinoma | 12 (42.9) |
| Neuroendocrine carcinoma | 1 (3.6) |
| Inducing chemotherapy before TRT | |
| Yes | 17 (60.7) |
| No | 11 (39.3) |